We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$469M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$38.7M |
| 2 |
Apple
AAPL
|
+$27.7M |
| 3 |
Salesforce
CRM
|
+$26.1M |
| 4 |
Verizon
VZ
|
+$25.9M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Waste Management
WM
|
+$64.8M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$58.6M |
| 4 |
Citigroup
C
|
+$56.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Oracle
ORCL
$345B
| $9.88M | 0.08% |
141,437
-4,468
| -3% | -$327K |
|
227
West Fraser Timber
WFG
$5.18B
| $9.66M | 0.08% |
126,133
+52,841
| +72% | +$4.45M |
|
228
Wabtec
WAB
$50.8B
| $9.57M | 0.08% |
116,666
+3,097
| +3% | +$276K |
|
229
DexCom
DXCM
$28.3B
| $9.52M | 0.08% |
127,699
+31,571
| +33% | +$2.88M |
|
230
Denali Therapeutics
DNLI
$3.74B
| $9.5M | 0.08% |
322,882
+181,375
| +128% | +$4.75M |
|
231
Relay Therapeutics
RLAY
$4.06B
| $9.34M | 0.08% |
557,817
+146,401
| +36% | +$3.14M |
|
232
Molina Healthcare
MOH
$10.4B
| $9.32M | 0.08% |
5,111
+2,083
| +69% | +$629K |
|
233
Caterpillar
CAT
$402B
| $9.27M | 0.08% |
51,857
-2,672
| -5% | -$563K |
|
234
Masco
MAS
$16.4B
| $9.25M | 0.08% |
182,910
+69,272
| +61% | +$3.66M |
|
235
Kymera Therapeutics
KYMR
$9.05B
| $9.25M | 0.08% |
469,860
+55,147
| +13% | +$1.29M |
|
|
MRSN
236
DELISTED
Mersana Therapeutics
MRSN
| $9.2M | 0.08% |
79,622
+5,829
| +8% | +$548K |
|
237
Cintas
CTAS
$84.4B
| $9.07M | 0.07% |
97,128
+66,984
| +222% | +$6.53M |
|
|
FOLD
238
DELISTED
Amicus Therapeutics
FOLD
| $9.01M | 0.07% |
+838,879
| New | +$6.91M |
|
239
Robert Half
RHI
$4.07B
| $8.96M | 0.07% |
119,691
+2,318
| +2% | +$220K |
|
240
Veeva Systems
VEEV
$31.6B
| $8.83M | 0.07% |
44,610
+19,596
| +78% | +$3.61M |
|
241
Deere & Co
DE
$169B
| $8.75M | 0.07% |
29,207
-452
| -2% | -$166K |
|
242
Republic Services
RSG
$66.7B
| $8.64M | 0.07% |
66,060
+36,500
| +123% | +$4.79M |
|
243
Replimune Group
REPL
$724M
| $8.61M | 0.07% |
492,504
| – | – |
|
244
Louisiana-Pacific
LPX
$5.19B
| $8.53M | 0.07% |
162,750
+53,692
| +49% | +$3.44M |
|
|
CMA
245
DELISTED
Comerica
CMA
| $8.46M | 0.07% |
115,312
+105,208
| +1,041% | +$8.5M |
|
246
Dover
DOV
$27.7B
| $8.46M | 0.07% |
69,739
-31,722
| -31% | -$4.29M |
|
247
American Tower
AMT
$77.7B
| $8.42M | 0.07% |
32,930
+1,119
| +4% | +$281K |
|
|
SPLK
248
DELISTED
Splunk Inc
SPLK
| $8.38M | 0.07% |
94,693
-27,852
| -23% | -$3.06M |
|
249
AvalonBay Communities
AVB
$26.8B
| $8.32M | 0.07% |
42,853
+30,392
| +244% | +$6.58M |
|
250
Cigna
CI
$77B
| $8.3M | 0.07% |
31,484
-23,088
| -42% | -$5.95M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2022 Portfolio in Review
As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.
- Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
- Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
- Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
- Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
- Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
- Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
- Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.
Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.